AmerisourceBergen (ABC) Receives a Buy from Deutsche Bank

In a report issued on July 18, George Hill from Deutsche Bank maintained a Buy rating on AmerisourceBergen (ABCResearch Report). The company’s shares closed last Tuesday at $145.20.

According to TipRanks.com, Hill is a 5-star analyst with an average return of 7.3% and a 55.2% success rate. Hill covers the Healthcare sector, focusing on stocks such as Molina Healthcare, 1Life Healthcare, and Cardinal Health.

Currently, the analyst consensus on AmerisourceBergen is a Moderate Buy with an average price target of $171.25, a 18.5% upside from current levels. In a report issued on July 13, Robert W. Baird also maintained a Buy rating on the stock with a $187.00 price target.

See the top stocks recommended by analysts >>

Based on AmerisourceBergen’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $57.72 billion and net profit of $548 million. In comparison, last year the company earned revenue of $49.15 billion and had a net profit of $435 million.

Based on the recent corporate insider activity of 69 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ABC in relation to earlier this year. Most recently, in May 2022, Lazarus Krikorian, the SVP & CAO of ABC sold 6,759 shares for a total of $1,072,191.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Read More on ABC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More